| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/28/2007 | US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2007 | US20070148088 Cytotoxic therapy |
| 06/28/2007 | DE102005054454A1 Verwendung von Choriongonadotropin als Immunsuppressivum Use of chorionic gonadotropin as an immunosuppressant |
| 06/28/2007 | CA2655448A1 Cyclic antimicrobial peptides |
| 06/28/2007 | CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation |
| 06/28/2007 | CA2634647A1 Metastin derivatives and use thereof |
| 06/28/2007 | CA2634608A1 Inhibition de la reponse immunitaire anti-fviii |
| 06/28/2007 | CA2634495A1 Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 06/28/2007 | CA2634363A1 Novel application of apelin |
| 06/28/2007 | CA2634292A1 Apoptosis-inducing protein complexes and therapeutic use thereof |
| 06/28/2007 | CA2634072A1 Markers for memory t cells and uses thereof |
| 06/28/2007 | CA2634034A1 Methods and compositions for delivering active agents with enhanced pharmacological properties |
| 06/28/2007 | CA2634026A1 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms |
| 06/28/2007 | CA2633264A1 Novel compounds which interact with pea-15 |
| 06/28/2007 | CA2633213A1 Soluble gp130 molecule variants useful as a medicament |
| 06/28/2007 | CA2632435A1 Soluble il-17rc variant and uses thereof |
| 06/28/2007 | CA2632400A1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 06/28/2007 | CA2632331A1 Molecules with a beta-aggregating region and their use in inducing protein aggregation |
| 06/28/2007 | CA2631811A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 06/28/2007 | CA2628558A1 Modified annexin proteins and methods for their use in organ transplantation |
| 06/28/2007 | CA2602042A1 Kit and composition of imidazole with enhanced bioavailability |
| 06/27/2007 | EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 06/27/2007 | EP1801204A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/27/2007 | EP1801124A1 Utilization of sperm membrane protein obf |
| 06/27/2007 | EP1801121A1 Soluble gp130 molecule variants useful as a medicament |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801119A1 Interleukin-15 antagonist peptide |
| 06/27/2007 | EP1800697A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas |
| 06/27/2007 | EP1800692A1 Novel adjuvant for subunit or component vaccines |
| 06/27/2007 | EP1800691A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 06/27/2007 | EP1800690A2 Use of fungal immunomodulatory protein |
| 06/27/2007 | EP1800689A1 Liquid preparation of physiologically active peptide |
| 06/27/2007 | EP1800687A2 Anionic polymers as toxin binders and antibacterial agents |
| 06/27/2007 | EP1800686A2 Anionic polymers as toxin binders and antibacterial agents |
| 06/27/2007 | EP1800134A2 Method for diagnosing and treating crohn's disease |
| 06/27/2007 | EP1799866A2 Modulating mxa expression |
| 06/27/2007 | EP1799865A2 Methods for the administration of iloperidone |
| 06/27/2007 | EP1799716A1 Anti-angiogenic peptide |
| 06/27/2007 | EP1799713A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/27/2007 | EP1799711A2 Protracted exendin-4 compounds |
| 06/27/2007 | EP1799709A1 Myostatin isoform |
| 06/27/2007 | EP1799708A2 Lipocalin protein |
| 06/27/2007 | EP1799707A1 Kunitz-type recombinant inhibitor. |
| 06/27/2007 | EP1799705A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 06/27/2007 | EP1799702A2 Inhibitors of protein kinase a anchoring |
| 06/27/2007 | EP1799701A2 Peptide inhibitors of hk2 and their use. |
| 06/27/2007 | EP1799700A2 Srage mimetibody, compositions, methods and uses |
| 06/27/2007 | EP1799264A2 Methods and compositions for treating migraine pain |
| 06/27/2007 | EP1799258A2 Methods for treatment of angiogenesis |
| 06/27/2007 | EP1799257A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 06/27/2007 | EP1799250A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/27/2007 | EP1799249A2 Glycopegylated interferon alpha |
| 06/27/2007 | EP1799248A1 Use of il-17f for the treatment and/or prevention of neurologic diseases |
| 06/27/2007 | EP1799247A1 Method for diagnosing and treating bone-related diseases |
| 06/27/2007 | EP1799246A1 Chimeric protein |
| 06/27/2007 | EP1799245A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 06/27/2007 | EP1799244A1 Furin inhibitors |
| 06/27/2007 | EP1799243A2 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
| 06/27/2007 | EP1799242A2 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 06/27/2007 | EP1799241A2 Combination therapy for the treatment of obesity |
| 06/27/2007 | EP1799240A2 Treatment of bone disorders with skeletal anabolic drugs |
| 06/27/2007 | EP1799229A1 Pulmonary administration of an antithrombotic compound |
| 06/27/2007 | EP1799192A2 Compositions and methods for treating excessive bleeding |
| 06/27/2007 | EP1799188A1 Use of peptides as an antioxidant agent for the preparation of a cosmetic and/or pharmaceutical composition |
| 06/27/2007 | EP1692504A4 Solution-based methods for detecting mhc-binding peptides |
| 06/27/2007 | EP1558728B1 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
| 06/27/2007 | EP1374898B1 Use of interleukin-12 for treating nerve damage |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1121436B1 Non-desensitizing ampa-receptors |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/27/2007 | EP1107743B1 Stable spray-dried protein formulations |
| 06/27/2007 | EP0981549B2 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 06/27/2007 | EP0980387B1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | EP0906760B1 Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof |
| 06/27/2007 | EP0817853B1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 06/27/2007 | CN1989410A Immune response assessment method |
| 06/27/2007 | CN1989245A Novel galectin 8 modification protein and use thereof |
| 06/27/2007 | CN1989244A Inhibitors of tgf-r signaling for treatment of cns disorders |
| 06/27/2007 | CN1989153A High affinity ny-eso t cell receptor |
| 06/27/2007 | CN1988916A Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage(ICH) |
| 06/27/2007 | CN1988915A Multiple agent therapy for sexual dysfunction |
| 06/27/2007 | CN1988914A Medical uses of intercellular communication facilitating compounds |
| 06/27/2007 | CN1988913A Bacteriophage and prophage proteins in cancer gene therapy |
| 06/27/2007 | CN1987465A Immune fluorescence grouping method |
| 06/27/2007 | CN1986785A Enzyme combining stabilizer |
| 06/27/2007 | CN1986568A INF-alpha expression relevant protein and its coding gene |
| 06/27/2007 | CN1986567A Japanese blood fluke specific female fluke sex gene and its coded protein and application |
| 06/27/2007 | CN1986566A Japanese blood fluke specific female fluke gene and its coded protein and application |
| 06/27/2007 | CN1986565A Japanese blood fluke specific sex relevant gene and its coded protein and application |
| 06/27/2007 | CN1986564A Japanese blood fluke specific female fluke gene and its coded protein and application |
| 06/27/2007 | CN1986563A Japanese blood fluke epidermal protein gene and protein and their application |
| 06/27/2007 | CN1985993A Compound preparation for enhancing memory |
| 06/27/2007 | CN1985992A New scheme of combining cell factor fusion protein (IL 2/FC) and compound Chinese medicine 861 for enhancing immune response of HB vaccine and breaking immune tolerance of HBV |
| 06/27/2007 | CN1985991A Recipe and preparing process of drug addiction eliminating medicine |
| 06/27/2007 | CN1985990A Composition and application of novel medicine package for preventing and treating women's cervical virus infection |
| 06/27/2007 | CN1985989A Slow released nano microsphere gel of alkaline fibroblast growth factor and polylactic acid and its preparing method |
| 06/27/2007 | CN1985988A Novel medicine composition for treating hepatic diseases |